Company Novacyt

Equities

ALNOV

FR0010397232

Biotechnology & Medical Research

Market Closed - Euronext Paris 12:27:16 2024-03-18 pm EDT 5-day change 1st Jan Change
0.54 EUR -0.92% Intraday chart for Novacyt +6.82% -24.26%

Business Summary

Novacyt develops, produces, and sells in vitro and molecular diagnostic products for the microbiology, haematology and serology markets. The activity is organized around two sectors:

- development of solutions and diagnostic services. The group is also developing a manufacturing activity for reagents and kits for bacterial and blood tests;

- manufacture and sale of molecular screening kits (Primerdesign): for laboratories.

Number of employees: 120

Sales per Business

EUR in Million2021Weight2022Weight Delta
Primer Design
93.3 %
105 93.8 % 23 93.3 % -77.99%
IT-IS International
6.7 %
11 9.7 % 2 6.7 % -84.60%
Intercompany Eliminations
-0.1 %
-9 -8.3 % 0 -0.1 % -99.86%

Sales per region

EUR in Million2021Weight2022Weight Delta
United Kingdom
48.1 %
50 44.6 % 12 48.1 % -76.14%
America
21.3 %
11 9.5 % 5 21.3 % -50.39%
Europe (Excluding United Kingdom)
18.3 %
38 33.9 % 5 18.3 % -88.06%
Asia-Pacific
8.8 %
11 9.9 % 2 8.8 % -80.35%
Middle East
1.8 %
1 0.7 % 0 1.8 % -47.11%
Africa
1.7 %
1 1.3 % 0 1.7 % -71.38%

Managers

Managers TitleAgeSince
Chief Executive Officer 58 21-01-04
Director of Finance/CFO 41 17-03-31
Chief Tech/Sci/R&D Officer - 16-04-30
Investor Relations Contact - 12-05-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 76 15-06-28
Director/Board Member 69 23-09-07
Director/Board Member 51 23-09-07
Chairman 58 14-09-30
Founder 73 06-07-02
Director/Board Member 57 17-06-26
Chief Executive Officer 58 21-01-04

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 70,626,248 68,226,800 ( 96.60 %) 16,993 ( 0.0241 %) 96.60 %

Shareholders

NameEquities%Valuation
Argenta Spaarbank NV
0.3982 %
281,236 0.3982 % 156 736 €
Eiffel Investment Group (Private Equity)
0.1458 %
102,990 0.1458 % 57 397 €
Lyxor International Asset Management SAS
0.1252 %
88,398 0.1252 % 49 265 €
43,839 0.0621 % 24 432 €
43,500 0.0616 % 24 243 €
33,981 0.0481 % 18 938 €
20,000 0.0283 % 11 146 €
Ed Snape
0.0254 %
17,919 0.0254 % 9 986 €
Quoniam Asset Management GmbH
0.0121 %
8,540 0.0121 % 4 759 €
Impact Asset Management GmbH
0.005048 %
3,565 0.005048 % 1 987 €

Company contact information

Novacyt SAS

13 Avenue Morane Saulnier

78140, Vélizy-Villacoublay

+33 1 39 46 51 04

http://www.novacyt.com
address Novacyt(ALNOV)